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Abstract
The aim of this exploratory study was to examine the possible mechanisms of behavioral change in a cognitivebehavioral
intervention supporting medication adherence in HIV-infected persons. A total of 60 persons currently under medical
treatment were randomized to psychotherapy or usual care and were compared with a sociodemographically matched group
of general psychotherapy clients. Outcome measures included therapy adherence using medication event-monitoring system
psychotherapeutic processes and changes of experience and behavior. The general psychotherapy group was initially more
distressed than HIV psychotherapy patients and reached higher levels of psychotherapeutic effect. In the HIV psychotherapy
patients, a significant effect was found for maintaining adherence to medical treatment (Weber et al., 2004). These findings
show that psychotherapy is a beneficial intervention for HIV-infected persons, and therapeutic alliance and activation of
resources do not differ from a general psychotherapy treatment. Differential effects were detected for specific process
variables, namely problem actuation.
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Maintaining adherence is one of the major challen-
ges in HIV-infected patients (Paterson et al., 2000).
Viral resistance can develop when drug levels are
insufficient to stop viral replication completely. Drug
resistance may lead to clinical progression in the
individual, and resistant organisms can be transmitted
to other persons. Yet adherence to drug therapy for
a chronic and incurable illness is demanding for
patients.
The World Health Organization has launched a
campaign to promote therapy adherence in the
treatment of chronic diseases (Sabate´, 2003). Defi-
nitions of adherence following Bissonnette (2008)
have been conceptualized in different ways among
the disciplines of medicine, psychology, and phar-
macy. In the case of HIV-infected participants, the
medical approach has been taken. It is highly
important for participants to meticulously follow
the instructions of the pharmacological treatment.
Thus, the focus of the psychological intervention has
to be on difficulties or personal barriers in order to
improve adherence to therapy.
Numerous predictors of adherence have been
recognized, including physicianpatient communica-
tion, organizational aspects of care settings, patient
characteristics (e.g., emotional issues, health status,
sociodemographic and behavioral variables, and
recreational drug use), mode of drug regimen (e.g.,
number of pills, dosing frequency; Nieuwkerk &
Oort, 2005), and adverse treatment events such as
side effect severity (Mannheimer, Friedland, Matts,
Child, & Chesney, 2002; Turner, 2002). In particu-
lar, depression, self-efficacy, and social support were
shown to distinguish between good and poor adher-
ence (Catz, Kelly, Bogart, Benotsch, & McAuliffe,
2000). Maintaining long-term treatment can be
particularly challenging when the treatment course
develops other than as expected, adverse blood
results occur, or patients suffer from other side effects
of the treatment. We assume that the fundamental
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precondition for maintenance of drug therapy is
the patient’s motivation and his or her readiness
for a behavior change (Prochaska, DiClemente, &
Norcross, 1992; Weber et al., 2004).
The impact of social support on enhancing quality
of life and adherence to medication in HIV-infected
persons has been investigated already (Gonzalez
et al., 2004; Simoni, Frick, Lockhart, & Liebovitz,
2002). However, only scant support for specific
interventions has been found (Fogarty et al., 2002;
Haddad et al., 2000; Haynes, McDonald, Garg, &
Montague, 2002; Haynes, McKibbon, & Kanani,
1996; McDonald, Garg, & Haynes, 2002). Recently
published data have shown some effects of group
cognitivebehavioral therapy (CBT) on changes in
risk behavior (Kalichman, Rompa, & Cage, 2005),
depressive symptoms, and social support (Carrico,
Antoni, Weaver, Lechner, & Schneiderman, 2005)
and modest effects on adherence (Wagner et al.,
2006): First results of an individual psychotherapy
intervention showed significant effects on adherence,
as discussed in Weber et al. (2004). No data exist on
meaningful factors or combination psychotherapy
for successful behavior change. A better understand-
ing of these factors could even help to maintain or
enhance medication adherence among persons who
do not seek psychotherapy. Additionally, knowledge
of how such intervention differing from a psy-
chotherapeutic process seems to be important in
terms of treatment improvements in HIV patients.
In general, psychotherapy to support behavior
change is based on several general principles. Grawe
(1997, 2004b) postulated four research-informed
mechanisms of change: mastery/coping, clarification
of meaning, problem actuation, and resource activa-
tion. All of these mechanisms of change might be
linked to outcome and be dependent on distinctly
different psychotherapeutic goals (i.e., supporting
adherence to therapy for HIV-infected persons vs.
reducing psychopathology in individuals receiving
outpatient psychotherapy).
In the first proposed mechanism of change*
mastery/coping*the patient and therapist approach
the problem in terms of ability. Therapeutic skills and
an appropriate understanding of the patient’s pro-
blem are essential for progress. In the second
mechanism*clarification of meaning*feelings (fol-
lowing Lazarus’s, 1991, appraisal theory of emotion)
are changed by approaching whatever the patient sees
as a threat to a personal goal in terms of its
motivational components (i.e., approach vs. avoid-
ance). Clarifying the meaning of a specific situation
or altering the importance of a personal goal may
change the patient’s feelings dramatically (Green-
berg, Rice, & Elliott, 1996). The third proposed
mechanism of behavior change is problem actuation,
which is based on the insight that automated behavior
and perception can be changed only by activating the
neural foundation, that is, by experiencing avoided
situations. The fourth, and possibly the most im-
portant, factor in effecting change are the patient’s
own resources; psychotherapy can only work with
what the patient brings into therapy. Resources such
as strong motivation, social resources, verbal capa-
city, and imagination are necessary ingredients for
therapeutic change (Gassmann, 2002).
Within this framework, the objectives of our 1-year
randomized trial were twofold: (a) to study patients’
reported changes in experience and behavior and
investigate the mechanisms of behavior change linked
to maintenance of adherence, and (b) to compare the
doseeffect relationship for the proposed mechan-
isms of change in the HIV psychotherapy group and
an age- and gender-matched sample of psychother-
apy patients in an outpatient setting (general psy-
chotherapy group).
Materials and Method
Participants
HIV-infected patients. Of 60 randomized HIV-
infected persons originally recruited, we were able to
analyze data from 53. Seven patients did not finish
the trial. One patient was erroneously randomized,
five dropped out during the study, and one died
(unrelated to the study). The final sample included
43 men (81.1%) and 10 women (18.9%) ranging in
age from 25 to 71 years (M44.3, SD10.7).
Twenty-nine were allocated to the standard of care
plus psychotherapy group (HIV psychotherapy
group), including 21 men (72.4%) and eight women
(27.6%) ranging in age ranged from 25 to 71 years
(M44.8, SD11.1). One participant did not
complete the questionnaires. Twenty-four partici-
pants were allocated to the standard-of-care control
group (HIV control group), including 22 men
(91.7%) and 2 women (8.3%) ranging in age from
31 to 65 years (M43.7, SD10.5). The allocation
schedule for the two treatment arms and three
different CD4 strata (00.05109/l, 0.0510.2
109/l, or0.2109/l), with randomly permuted
block sizes of two and four, was generated in advance
with the program RANCODE V 3.0 (IDV Datena-
nalyse und Versuchsplanung, Gauting, Germany)
and properly concealed from care providers. CD4 is
an indicator of the degree of HIV infection and was
used in this study to stratify the treatment arms. CD4
is a primary receptor used by HIV-1 to gain entry into
host T cells.
General psychotherapy patients. A group of 28
patients from a psychotherapeutic ambulatory facil-
ity (outpatient clinic of the University of Bern,
204 H.-J. Znoj et al.
D
o
w
n
lo
ad
ed
 B
y:
 [
Un
iv
er
si
ta
t 
Zu
ri
ch
] 
At
: 
08
:3
2 
13
 A
pr
il
 2
01
0
Switzerland) matched on sociodemographic factors
(age and gender) formed a comparison group for the
intervention arm of the HIV-infected persons (psy-
chotherapy). The participants in this group suffered
from a variety of psychopathological disorders,
mainly anxiety disorders (50%) and depression
(30%). In contrast to the HIV group, members of
the comparison group had chosen psychotherapeutic
treatment of their own accord or had been recom-
mended for psychotherapy by health authorities.
The participants of this group included 21 men
and seven women ranging in age from 31 to 62 years
(M40.6, SD7.9). The mean number of sessions
for members of the comparison group was 33.2
(SD17.3, range 1177).
In the beginning, members of the general psy-
chotherapy group had higher levels of distress (M
1.03, SD0.52) than the HIV psychotherapy group,
as measured with the Symptom Checklist-90-
Revised (SCL-90-R) Global Severity Index (GSI).
The mean pretreatment GSI was 0.55 (SD0.39)
for participants receiving psychotherapy (N29)
and 0.42 (SD0.47) for controls (N24). There
was no posttreatment (i.e., after 12 months) differ-
ence between groups. Goal attainment scaling was
used to identify personal therapeutic goals in the
HIV-infected group as well as in the matched general
psychotherapy group. For the HIV intervention
group the principal therapeutic goal was adherence
to therapy. This principal goal had to be the main
focus of their therapeutic intervention. Additional
individual goals might have been formulated indivi-
dually. In contrast, for the matched general psy-
chotherapy group, the principal outcomes were
assessed individually in terms of each person’s major
complaint without any restrictions in terms of
treatment goals.
Therapists
Intervention was provided by licensed psychothera-
pists in private practice. All of them had formal
training in CBT, had heard a 2-hr lecture on antire-
troviral therapy before the study, and were instructed
to focus on the maintenance of antiretroviral drug
adherence. They were free to work as they saw fit on
any other problem the patient presented to them.
The sessions were all tape-recorded and psychothera-
pists were closely supervised.
Design
We conducted a prospective, controlled 12-month
trial with 60 HIV-infected persons on antiretroviral
combination therapy who were 1:1 randomized
to receive standard of care or standard of care
plus individual cognitivebehavioral intervention
provided by psychotherapists. Study design and
patient selection have been described elsewhere
(Weber et al., 2004). Inclusion criteria were as
follows: antiretroviral therapy containing a combina-
tion of at least three different drugs of at least two
different drug classes, viral load below 50 copies/ml,
participation in the Swiss HIV cohort study, and no
intravenous drug use (or, in case of drug addiction, on
stable methadone maintenance). Ethics committee
approval was obtained, and all participants gave
written informed consent. Standard of care and study
consultations of each patient were provided by the
same physician at the University Hospital HIV out-
patient clinic in Zurich, Switzerland. After randomi-
zation, participants in the intervention arm received
the address of one of the psychotherapists and were
asked to schedule a first appointment. The allocation
of participants to psychotherapists was random,
based on the number of participants each psy-
chotherapist indicated before the start of the study
that they would care for. The study protocol specified
a minimum of three and a maximum of 25 sessions
within the 1-year study period. Within these bounds,
appointment frequency was worked out by partici-
pants and psychotherapists during the course of the
study. Intervention sessions lasted 45 min on average.
The mean number of sessions per participant was
12.8 (SD6.8). Participants were informed that the
intervention was not proposed to address a psycho-
logical problem or psychiatric disease but rather to
support adherence to drug therapy using CBT.
Psychotherapists were instructed to define at first
visit, together with the participants, at least two goals
for future intervention. At least one of these goals had
to be related to adherence to antiretroviral therapy,
but participants and psychotherapists were free to
identify additional goals not related to HIV therapy.
Interventions had to be based on concepts of CBT
(Bandura, 1977).
Measures
Adherence measure. Medication intake in the
intervention and control groups was assessed using
the eDEM medication event-monitoring system
(Aardex Ltd., Zug, Switzerland; Cramer, Mattson,
Prevey, Scheyer, & Quellette, 1989). The study nurse
working closely with the physician downloaded the
monitoring data monthly to a central database in the
presence of the participants, who saw their own
performance on screen as a graphic, depicting times
at which pillboxes were opened during the previous
month. We used the measurements for the first
month of the study to approximate baseline values.
Psychosocial measures. The German translation
of Derogatis’s SCL-90-R (Franke, 1995), a struc-
tured and standardized questionnaire, was used at
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baseline and at 12 months to screen for nine
symptoms of psychopathology (e.g., depression,
anxiety) and to measure GSI, intensity of symp-
toms, and number of self-reported symptoms. Base-
line measurements from these instruments were
evaluated using a computer program and the results
transferred at once to the appropriate psychothera-
pists. Compared with a group of healthy individuals
(Franke, 1995), mean GSI was slightly higher in
our HIV group; however, mean values were lower
than in a comparable group of HIV-infected persons
(Franke, Ja¨ger, & Sta¨cker, 1995). Psychometrically,
the SCL-90-R showed excellent reliability in the
HIV sample (Cronbach’s a.94).
The structured and standardized questionnaire
Vera¨nderungsfragebogen des Erlebens und Verhal-
tens (VEV-VW; Zielke & Kopf-Mehnert, 1978; Will-
utzki, 1999) was used at 6 and 12 months to assess
changes of experience and behavior as perceived by
participants themselves. The questionnaire consisted
originally of 27 bipolar items that are answered on a
7-point Likert scale (e.g., ‘‘I am more relaxed’’ vs.
‘‘I am more tense’’). The total score is indicative of
‘‘quietness, confidence, optimism’’ versus ‘‘stress,
uncertainty, pessimism’’ (Weber et al., 2004). For
the present study, the VEV questionnaire was re-
duced to 17 items. Psychometrically, the shortened
VEV showed excellent reliability in the HIV sample
(Cronbach’s a.96).
Therapy process assessment. Psychotherapists kept
a record on qualitative information and used goal
attainment scaling (Kiresuk & Lund, 1978) to
identify intervention goals. Therapeutic process
was assessed by a theory-driven postsession report
(Regli & Grawe, 2000) completed by therapists and
patients independently. Items on the postsession
report were formulated according to the four postu-
lated mechanisms of change (Grawe, 1997). Addi-
tional items examined progress made during the
session.
An example item in the mastery/coping category
for patients is ‘‘I feel competent in situations I didn’t
feel competent in until now.’’ The same category was
rated by the therapists in response to such items as
‘‘Today, I have actively worked on helping the patient
to cope with situations that are difficult for him or
her to handle.’’ Reliabilities of patient and therapist
scales differed greatly. Cronbach’s a ranged from .16
to .77 for patients and from .26 to .93 for therapists.
Because both patients and therapists focused on
the same change mechanisms, we built a single scale
using the two perspectives. For reliabilities of the
combined scales, see Table I.
For patients, clarification of meaning included
such items as ‘‘Today possible solutions for my
problems (fulfillment of wishes, reaching my goals)
have been clarified.’’ For therapists, a typical item was
‘‘I have actively aimed at helping the patient to see
new connections in relation to his or her problems
(needs and goals).’’ For patients, problem actuation
included such items as ‘‘What we covered in today’s
session was at times very unpleasant.’’ For therapists,
a typical item was ‘‘Today I aimed deliberately at
involving the patient’s feelings.’’ Patient resource
activation items included, for example, ‘‘Right now
I feel supported by the therapist in the way I like to
be.’’ For therapists, a typical item was ‘‘In today’s
session I have actively tried to activate and specifically
use the patient’s resources.’’ Therapeutic alliance is
seen as a specific resource within the psychotherapy
situation. For patients, an exemplary item on this
scale was ‘‘Today I felt comfortable in the relationship
with the therapist.’’ Most items were negatively
labeled, as, for example, ‘‘I believe that the therapist
could attend more to my feelings.’’ For therapists,
items included statements like ‘‘Today I felt comfor-
table in the relationship with the patient.’’ The
postsession reports for both patient and therapist
included a scale for felt therapeutic progress. The
patient postsession report also included items for
corrective experiences and self-efficacy.
Statistics
Statistical analysis was performed using parametric
methods for comparisons of independent and de-
pendent samples. To identify time trends in adher-
ence as measured by medication event-monitoring
system, we calculated a slope for each patient using
linear regression. We then tested whether adherence
slopes for patients from the intervention and control
groups differed from each other (analysis of variance
repeated measurement design). We used correlations
as a measure of association. Additionally, reliability
scores for the process scales were calculated sepa-
rately for HIV participants and outpatient psy-
chotherapy participants (see Table I). To improve
reliability, patient and therapist perspectives were
taken together. Means and standard deviations
reflect the combined perspective in Table I.
Results
Effects of Psychological Intervention
Of the 23 persons in the psychotherapy treatment
group who completed psychotherapeutic treatment,
16 maintained initial high medication adherence. In
the control group, only five of 24 maintained initial
high adherence.
Apart from the positive effect of psychotherapy on
adherence (see Weber et al., 2004), a major effect on
changes of experience and behavior, such as feeling
206 H.-J. Znoj et al.
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more confident and relaxed, more optimism, and a
better sense of coming to terms with their problems,
F(1, 53)6.81, p.01, was found. Moreover, the
total score of changes of experience and behavior
correlated significantly with adherence slope (r
0.29, pB.05), and participants with better adherence
improved more reliably in experience and behavior.
Participants with 10 or more cognitive behavior
interventions experienced more improvement; these
results were presented and discussed in Weber et al.
(2004). A comparison of the two median-split groups
(improved adherence and not improved adherence)
revealed a significant difference between them,
F(1, 38)9.16, pB.01.
Psychotherapy Process in the HIV Psychotherapy
Group
Table II shows the productmoment correlations
between changes of experience and behavior and
measures of process such as therapeutic alliance,
activation of resources, and clarification of meaning.
For this purpose, the process measures have been
averaged over the entire course of each individual
treatment. Therefore, the correlations in Table II do
not show process over time but global association
with changes of experience and behavior. These
correlations in the table suggest that the associations
between process variables and variables of micro-
outcome strengthen over the course of treatment with
the global outcome, as measured with the VEV.
However, this is not the case for some process vari-
ables. The strongest effect is on corrective experi-
ences, a clear measure of micro-outcome.
Our main hypothesis was that participants of the
psychotherapy treatment group, who experienced
more improvement in adherence and changes of
experience and behavior, would also show higher
levels of involvement in therapeutic process, as
measured by the four process variables. Accordingly,
we median-split the psychotherapy group sample by
high versus low changes of experience and behavior
(low VEV and high VEV) at the end of therapy into
not improved (low VEV) and improved (high VEV)
and tested against the course of the process variables.
The course of the psychotherapy was aggregated into
three phases, following Howard and others (Howard,
Orlinsky, & Lueger, 1994; Hill & Lambert, 2004).
This was necessary because of the large differences in
treatment length and number of sessions. As a
Table I. Descriptives and Reliability of Process Variables Measured by Postsession Report
HIV psychotherapy (n28) General psychotherapy (n28)
Process variable (no. items) M (SD) a M (SD) a
Mastery/coping (4) 0.33 (0.56) .73 0.35 (0.48) .74
Clarification of meaning (6) 0.30 (0.63) .81 0.26 (0.58) .66
Problem actuation (5) 0.53 (0.54) .81 0.63 (0.51) .76
Resource activation (6) 0.15 (0.77) .86 0.07 (0.64) .79
Therapeutic alliance (4) 0.12 (0.77) .68 0.00 (0.71) .82
Progress in therapy (3) 0.50 (0.76) .74 0.44 (0.40) .61
Corrective experiences (5) 0.41 (0.86) .83 0.35 (0.58) .81
Self-efficacy (3) 0.55 (0.79) .77 0.45 (0.62) .73
Note. Means and standard deviations are calculated for z-transformed data to obtain the same metric for the two samples (pooled sample
from all measurements). The variables corrective experiences and self-efficacy were scales of the patient postsession report, so only the
patient’s perspective is represented by these variables. The other process variables are combined values of therapist and patient perspectives.
Table II. Correlations of Process Variables and Variables of Micro-Outcome with Change of Experience and Behavior (VEV) at the End of
Therapy in the HIV Psychotherapy Group
Process variable Phase 1 Phase 2 Phase 3 Whole therapy
Mastery/coping .12 .32 .65** .49*
Clarification of meaning .41* .18 .54** .48**
Problem actuation .03 .15 .13 .00
Resource activation .42* .48* .45* .50**
Therapeutic alliance .28 .41* .24 .35
Progress in therapy .45* .56** .50** .55**
Self-efficacy .05 .48* .40* .36
Corrective experiences .32 .40* .70** .53**
Note. N28. Phases 1 to 3 represent the course of psychotherapy divided into three phases. Whole therapy denotes the average over all
phases and represents the degree of association of the process variables with change at the end of therapy. VEVVera¨nderungsfragebogen
des Erlebens und Verhaltens.
*pB.05. **pB.01.
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baseline for each patient, we used the values of the
first session.
Therapeutic alliance did not differ between the
improved and not-improved groups, and there was
no effect for course or interaction between course and
group for therapeutic alliance. Activation of re-
sources tended to separate the two outcome groups,
F(1, 25)3.30, pB.10, h2.12, but there was no
effect for course or any interaction between groups
and time course. For clarification of meaning, there
was a tendency for an effect between groups,
F(1, 25)2.74, p.11, h2.10, and for an effect
of time course, F(1, 25)3.90, pB.10, partial
h2.14, indicating a negative slope toward the end
of therapy in both groups. For mastery/coping, there
was no main effect between the two groups but a
trend for a statistical interaction between time course
and VEV outcome, F(1, 25)3.51, pB.10, partial
h2.12. The latter indicated that the HIV patients
who gained more in the psychotherapeutic treatment
improved in mastery/coping, as seen by both them-
selves and therapists, in contrast to the not-improved
group. For problem actuation, we found no differ-
ences between the two groups.
Micro-outcomes (i.e., corrective experiences and
self-efficacy, as reported by the patient, and progress
in therapy, as rated by patients and therapists) also
separated the two groups, indicating that patients and
therapists were good judges of the ongoing process.
For corrective experience, this effect was highly
significant between the improved and not-improved
groups, F(1, 25)8.23, pB.01, partial h2.25, and
there was an additional interaction effect between the
outcome groups and time course, F(1, 25)3.29,
pB.01, partial h2.12. Progress in therapy also
separated the two groups, F(1, 25)6.16, pB.05,
partial h2.20. There was an expected interaction
tendency in that persons in the improved outcome
group also reported more self-efficacy in the course of
the psychotherapeutic intervention, F(1, 25)2.77,
pB.10, partial h2.10. Figure 1 (AD) shows the
reported effects between the two outcome groups of
HIV-infected persons in the four proposed process
variables.
Comparison of HIV Psychotherapy and General
Psychotherapy Groups
A comparison of psychological outcome measures
confirmed two effects: Patients in the general psy-
chotherapy group (a) were initially more distressed,
as measured with the SCL-90-R GSI, and (b)
reached higher levels of effect (prepost) compared
with those in the HIV psychotherapy group.
The outpatient group completed the same post-
session reports as the main study group, and we felt
that we could compare the process variables. How-
ever, it should be noted that the average duration of
therapy for the outpatient group was more than 30
sessions compared with 13 sessions for the HIV-
infected group.
We hypothesized that in self-referred psychother-
apy (the outpatient clinic group) the mechanisms of
change would be more pronounced and result in
greater change. In Table III, group comparisons for
the five mechanisms of change (counting therapeutic
alliance) and the three micro-outcomes (progress in
therapy, corrective experiences, and self-efficacy) are
given.
Figure 2 (AD) depicts the averaged phases in the
four process variables for the main and comparison
groups. Although all differences were in the pre-
dicted direction, the effect on problem actuation was
larger than expected. There were no differences
between the two groups in terms of resource activa-
tion and therapeutic alliance. The differences be-
tween the two groups over the course of treatment
included the first session (baseline), with the excep-
tion of clarification of meaning, for which there was
one significant interaction (GroupTime Course).
Again, the direction of the effect was as expected:
Over the course of treatment, outpatients choosing
psychotherapy reported more clarification of mean-
ing than those randomly assigned to psychotherapy
in the main study group.
Discussion
We studied the relationship between adherence and
change of experience and behavior. Furthermore, we
were interested in the postulated mechanisms of
change and outcome in HIV-infected patients during
psychotherapy. We hypothesized that adherence and
change of experience are related. We obser-
ved that the change of experience and behavior was
associated with improved adherence. Therefore,
psychotherapy might be a beneficial intervention for
HIV-infected persons undergoing a challenging drug
treatment. This result enhances and builds upon the
finding of Weber et al. (2004) of a significant relation-
ship between adherence and psychotherapy. Further-
more, members of the HIV psychotherapy group
reported greater improvement in their mental health
and behavior during the study period than did
members of the HIV control group. This improve-
ment correlated with number of sessions (i.e.,
patients having 10 or more consultations with a psy-
chotherapist reported more improvement than those
who had fewer). The cost of the additional interven-
tion approximates the cost of 1 month of the standard
triple-antiviral regimen (Weber et al., 2004).
208 H.-J. Znoj et al.
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More specifically, we hypothesized that HIV-in-
fected patients with improvements in adherence and
changes of experience and behavior show higher
levels of involvement in therapeutic process. We
observed that almost all proposed mechanisms of
therapy such as mastery/coping, clarification, re-
source activation, and therapeutic alliance correlated
with both medication adherence and perceived im-
provement in mental health and behavior. However,
detailed results of involvement in therapeutic process
measured by four process variables*therapeutic
alliance, activation of resources, clarification of
meaning, and mastery/coping*were rather inconsis-
tent. When the intervention group was separated into
those who perceived high mental health and behavior
benefit (improved group) and those who perceived
low benefit (not improved), analysis suggests that the
former were more deeply involved in the psychother-
apeutic process and, therefore, benefited from higher
levels of the proposed mechanisms of change. This
effect could not be attributed to therapeutic alliance:
Patients and therapists of both the improved and the
not-improved groups rated the quality of the ther-
apeutic alliance at about the same level. As a result of
relatively small sample sizes, it must be considered
that results could reflect a Type II error (b error).
Additionally, the exploratory approach in this study
has to be considered. Nonsignificant findings should
not be interpreted because of weak power, whereas
significance might be effected by exploratory multiple
testing and, therefore, should be interpreted with
caution.
Furthermore, in comparing the HIV-infected psy-
chotherapy group and an outpatient clinic group of
individuals with self-referred psychotherapy, we hy-
pothesized that mechanisms of change would be
more pronounced and result in greater change in
the latter. We observed that the two groups did not
differ in basic ingredients of psychotherapeutic
change such as therapeutic alliance and activation
of resources in contrast to problem actuation. These
results seem to indicate an important message: In
order to change patterns of problematic behavior and
experience, problems have to be activated. Hence,
Figure 1. (AD) The z-transformed scores of four process variables for the HIV psychotherapy group in the randomized trial median-split
with high and low changes in experience and behavior (Vera¨nderungsfragebogen des Erlebens und Verhaltens). The first session is the
baseline; the three phases are average scores for sessions in the beginning, middle, and end phases of therapy.
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problem actuation will occur only with sufficient
motivation for psychological change. Further, we
would expect mastery/coping and clarification of
meaning to occur simultaneously, and this is indeed
what the data suggest: Both these process variables
differ largely between the two groups, again in the
expected direction. Likewise, the micro-outcomes, as
judged by patients and therapists, differed highly
significantly between the two groups, showing med-
ium to large effect sizes. The differences in motiva-
tion for treatment and amount of psychological
distress during pretreatment do not reduce these
findings.
Adherence to medication is an immense task: Not
only must one swallow many pills a day (often more
than 10), but some of these pills have to be ref-
rigerated, some taken before meals, some after, and
some at regular times each day. An HIV-positive
person often has other difficulties as well (Folkman,
1997), such as facing the illness and death of loved
ones. Results of our study suggest that supportive
intervention, especially clarification of meaning, can
improve quality of life for HIV-infected persons. By
helping patients focus on new relations and new
perspectives, therapists can actively turn ‘‘lead into
gold’’ (Taylor & Brown, 1988), installing a positive
feedback loop that helps them maintain good
humor, high self-esteem, and good affect regulation.
In particular, an intervention based on cognitive
behavioral techniques seems to help HIV-infected
persons maintain high medication adherence.
Limitations
To our knowledge, this is the first study to assess the
process of behavioral change in a randomized
controlled trial involving HIV-infected persons.
The change aimed for was maintaining medication
adherence, which limits the cognitivebehavioral
intervention to a single problem. The randomized
design did not account for clinical considerations or
the individual needs of patients. However, partici-
pants in the intervention arm were free to quit the
additional treatment as they wished. The average
number of sessions was relatively low considering
that patients were not charged for therapy (weekly
individual sessions) and were free to discuss further
personal problems in addition to adherence. How-
ever, nobody quit, and some patients attended the
maximum number of sessions.
The relatively large range of participation in the
intervention group posed problems in terms of
process research. We followed a rather simple rule,
dividing all interventions into three parts or phases:
beginning, middle, and end of psychological inter-
vention. Another difficulty was assessment of process
variables. There is a large and still growing body of
literature concerning the question of the process
outcome relationship in psychotherapy (Orlinsky,
Rønnestad, & Willutzki, 2004). We solved this pro-
blem by using a theory-driven measurement of
postsession reports completed both by therapist and
patient to obtain reliable scales of clinically relevant
psychotherapy process variables (Lambert & Ogles,
Table III. Results of the Analysis of Variance Repeated Measurement Design of Process Variables Comparing the HIV Psychotherapy
Group (n28) and the Demographically Matched General Psychotherapy Group (n28)
Process variable F df h2
Between-subject effects
Mastery/coping 24.12** 1, 54 .31
Clarification of meaning 11.86** 1, 54 .18
Problem actuation 67.03** 1, 54 .55
Resource activation 1.32 1, 54 .02
Therapeutic alliance 0.38 1, 54 .01
Progress in therapy 33.65** 1, 54 .38
Corrective experiences 14.93** 1, 54 .22
Self-efficacy 27.84** 1, 54 .34
Interaction effects (Time CourseGroup)
Mastery/coping 0.50 2,108 .02
Clarification of meaning 3.85* 1.86,a 108 .07
Problem actuation 0.20 2, 108 .01
Resource activation 1.46 2, 108 .05
Therapeutic alliance 0.93 1.66,a 108 .01
Progress in therapy 2.01 2, 108 .07
Corrective experiences 0.37 2, 108 .01
Self-efficacy 1.06 1.69,a 108 .02
Note. Within effects were suppressed for this table.
aWith HuynhFeldt correction.
*pB.05. **pB.01.
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2004). Orlinsky and Howard (1978) have stressed the
importance of an experiential perspective on the
events of therapy. By using self-report, we emphasize
the experience of both patients and therapists rather
than ‘‘objective’’ observer criteria. The postsession
report used in this study had been revised several
times, gradually integrating scales for change me-
chanisms (Grawe, 2004b).
We focused on mastery/coping, clarification of
meaning, and problem actuation as mechanisms of
change. Arguably, other variables are also involved in
psychotherapy, such as emotional regulation mechan-
isms (Mergenthaler, 1996; Znoj, Nick, & Grawe,
2004), motivational processes (Jeger, Znoj, & Grawe,
2003; Schulte, Hartung, & Wilke, 1997; Znoj et al.,
2000), and cognitive processes such as assimilation
of problematic experiences (Stiles, 2002).
The method of measuring mechanisms of change
used here has the advantage of not requiring great
research investment; combining the perspectives of
patient and therapist creates relative objectivity. The
process variables in this study have theoretically been
linked to the outcome (Grawe, 2004a), but it is
unclear to what extent these process variables might
influence each other. There is a strong body of
evidence that these variables are not independent.
For instance, Gassmann (2002) showed that a strong
focus on problem activation without resource activa-
tion leads to an impaired session outcome and that
the interplay between these two variables is impor-
tant for the outcome of psychotherapy. Our focus in
this study was mainly to show that the postulated
process variables are linked to the outcome. The
results in the primary study, which showed differ-
ential use of change mechanisms, were confirmed
in the comparison study. Most interestingly, the
so-called basic requirements of psychotherapy*
working alliance and resource activation*were not
observed to differ in the two studies. We focused on
change of experience and behavior (VEV) as the main
outcome measure because the HIV treatment group
showed very low signs of psychological disturbances
Figure 2. (AD) The z-transformed scores of the process variables in the HIV psychotherapy (PT) group and in the general psychotherapy
group. The first session is the baseline; the three phases are average scores for sessions in the beginning, middle, and end phases of therapy.
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as rated by the SCL-90-R. This fact limits the
possible improvements resulting from psychological
interventions.
In the first analysis there was a trend indicating that
the improved subgroup of HIV-infected persons
experienced more resource activation during the
sessions; however, in contrast to our assumptions,
in the HIV intervention group problem actuation was
not related to outcome. This could be due to the
relatively low psychological distress of the HIV-
infected persons in this study. In fact, the GSI for
participants in this study was even lower than in a
normative sample of HIV-infected men (Franke et al.,
1995). This might be a result of the highly effective
medication treatment administered to participants in
the present study. It is important to stress that all
participants in the study were selected randomly
(Weber et al., 2004).
A limitation of this study concerns the manipula-
tion check and treatment in general. There was no
systematic manipulation check in this study. How-
ever, all therapists of the HIV intervention group
were supervised in terms of the main treatment goals,
namely improvement of the adherence to medical
therapy. The small sample size of the HIV interven-
tion group and the post hoc approach that was
followed in this research reduce the power of the
presented analyses and the generalizability of the
results. To our knowledge, this is the first study
regarding processoutcome research in HIV patients.
Therefore, an exploratory approach was appropriate.
Although many of the contrasts do not reach statistic
significance, the given effect sizes show that this
might be due to lack of statistical power. The results
of this study have to be reproduced in larger samples
and in a priori research designs.
Open Questions and Future Research
The psychotherapists in this study received no
instruction aside from a lecture on HIV treatment
and a mandate to focus on adherence. This leaves
room for improvements; for instance, more focused
interventions, enhanced support, or focus on positive
states of mind (Gonzalez et al., 2004) might improve
effectiveness. Some individuals may need clarifica-
tion of motives, fears, or a grief-related topic; others
lack social support; and still others lack specific skills
for maintaining medication adherence. So far, stu-
dies comparing group versus individual interventions
and the various interventions for groups are lacking.
We hope that this study’s focus on process will
lead to more investigations of topics related to
adherence. Referral to mental health specialists is a
possible tool for maintaining medication adherence
for people infected with HIV. Further, policymakers
should note that individual psychological interven-
tion is inexpensive compared with treating the
medical consequences of nonadherence.
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